Vinorelbine Suppliers & Bulk Manufacturers

Available Forms: Intravenous Injection, Oral Capsule

Available Strengths: Injection: 10 mg/mL; Capsule : 20 mg, 30 mg, 40 mg

Reference Brands: Navelbine® , Alocrest (US & EU)

Category: Oncology Cancer Care

Vinorelbine (brand Navelbine®) is a chemotherapy drug used for non-small cell lung cancer and advanced breast cancer. Available as IV injection (10 mg/mL) and oral capsules (20 mg, 30 mg, 40 mg), it disrupts microtubule formation to stop cancer cell division. Sourced by GMP-compliant B2B suppliers, it is widely available in the US and EU for reliable oncology treatment. Vinorelbine is available in Intravenous Injection, Oral Capsule and strengths such as Injection: 10 mg/mL; Capsule : 20 mg, 30 mg, 40 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Vinorelbine is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Vinorelbine can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Vinorelbine, marketed as Navelbine®, is an essential chemotherapy agent used for the treatment of non-small cell lung cancer (NSCLC) and advanced breast cancer. Available as an intravenous injection and oral capsules, with strengths like 10 mg/mL (IV) and 20 mg, 30 mg, and 40 mg (oral), Vinorelbine inhibits cell division by disrupting microtubule formation. Widely sourced by B2B pharmaceutical suppliers, Vinorelbine is available globally, including in the US and EU. Manufactured under GMP standards, it provides reliable therapy options for hospitals and oncology centers fighting aggressive cancers.